Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
SO Southern Co
ASPZ Asia Properties Inc
BCAUY Brilliance China Automotive Holdings Ltd
RBC Regal Beloit Corp
WTRG Essential Utilities Inc
GRX Gabelli Healthcare & WellnessRx Trust
MILEW Metromile Inc *W EXP 02/09/2026
BRP BRP Group Inc
CMG Chipotle Mexican Grill Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada and Atripla. It offers Veklury to patients with COVID-19. The Company's products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Viread and Vosevi. Its products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy and Zydelig. Other products include Letairis, Ranexa and AmBisome. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The Company operates in more than 335 countries worldwide.

Price
Delayed
$71.80
Day's Change
0.105 (0.15%)
Bid
--
Ask
--
B/A Size
--
Day's High
71.87
Day's Low
71.48
Volume
(Below Average)

Today's volume of 535,307 shares is on pace to be lower than GILD's 10-day average volume of 7,285,867 shares.

535,307
Latest Earnings Beat Consensus (Q2 ending 06/2021)Next Earnings Announcement
Q2
Announced July 29, 2021
$1.87Q2 Consensus
of 22 analysts
$1.73Difference from
consensus
7.27%
Q3 Earnings
will announce
(Unconfirmed) October 26, 2021

Quarterly Earnings History and Estimates

Show high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

Display:

UpdateCancel

GILD's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.